all Kenneth R. Chien stories

From stem cells to functioning strip of heart muscle

404132862 — Thu, 15 Oct 2009 14:00:00 -0400

A team of Harvard Stem Cell Institute (HSCI) scientists at Massachusetts General Hospital (MGH) and collaborators at Harvard’s School of Engineering and Applied Sciences (SEAS) has taken a giant step toward the possibility of using human stem cells to repair damaged hearts.

Harvard team grows heart muscle from stem cells

404132862 — Thu, 15 Oct 2009 17:18:08 -0400

Need a new heart? Grow your own

404132862 — Sat, 10 Oct 2009 13:07:34 -0400

Three Harvard teams to receive $9 million each in federal funding for stem cell research

404132862 — Thu, 08 Oct 2009 10:11:45 -0400

Three teams of Harvard Stem Cell Institute (HSCI) researchers are slated to receive $27 million over seven years in National Heart Lung and Blood Institute (NHLBI) grants for the development of stem-cell based tools and treatments to understand and treat cardiovascular and blood disorders. The NHLBI Progenitor Cell Biology Consortium will consist of nine research hubs, each involving multidiscplinary teams from two academic medical centers.

Scientists find master heart cell - Harvard discovery gives new tools for drug development

404132862 — Thu, 02 Jul 2009 14:06:21 -0400

Human cardiac master stem cells identified

404132862 — Wed, 01 Jul 2009 12:59:00 -0400

Harvard Stem Cell Institute researchers at Massachusetts General Hospital have identified the earliest master human heart stem cell from human embryonic stem cells - ISL1+ progenitors - that give rise to a family of cells that form the essential portions of the human heart.

GlaxoSmithKline and Harvard Stem Cell Institute announce major collaboration agreement

404132862 — Mon, 21 Jul 2008 15:00:05 -0400

GlaxoSmithKline (GSK) and the Harvard Stem Cell Institute (HSCI) today announced that they have entered into a five-year, $25 million-plus collaborative agreement to build a unique alliance in stem cell science to hasten the development of treatments and cures for a range of diseases.

Stem cells open window on disease processes

404132862 — Fri, 14 Mar 2008 13:54:34 -0400

A panel of Harvard Stem Cell Institute experts said recently that stem cell research’s biggest impact on patients’ health likely won’t come from therapies that inject stem cells or implant tissues made from them, but rather from the knowledge gained by examining diseased tissues grown from the cells.